Market Place
Sourcing Support
Biosimilars & innovation are Dr. Reddy’s growth pill
23 Feb 2026 //
ECONOMICTIMES
Dr. Reddy`s Gains FDA Review For Orencia Biosimilar
20 Feb 2026 //
PRESS RELEASE
Coya Therapeutics Announces $11.1 Million Private Placement
30 Jan 2026 //
BUSINESSWIRE
Dr. Reddy`s Launches Hepatitis E Vaccine `Hevaxin` In India
07 Jan 2026 //
PRESS RELEASE
Coya Therapeutics Begins COYA 302 Dosing in ALSTARS Trial
09 Dec 2025 //
PRESS RELEASE
Dr. Reddy`s Receives EC Approval For AVT03: Biosimilar Launch
24 Nov 2025 //
PRESS RELEASE
EMA Recommends Marketing Authorization of AVT03
22 Sep 2025 //
GLOBENEWSWIRE
Alvotech & Dr. Reddy’s Collab to co-develop Keytruda
05 Jun 2025 //
PRESS RELEASE
Dr. Reddy`s aims for top five in Indian market
10 May 2025 //
ECONOMICTIMES
Dr Reddy`s to introduce Sanofi`s novel drug in India
29 Apr 2025 //
PRESS RELEASE
Bio-Thera, Dr. Reddy`s sign exclusive deal for Stelara and Simpon
28 Mar 2025 //
PRESS RELEASE
Alvotech & Dr. Reddy’s Announce FDA acceptance of BLA for AVT03
19 Mar 2025 //
PRESS RELEASE
Henlius & Dr. Reddy`s Ink Licensing Deal for HLX15 Expansion in Europe & US
07 Feb 2025 //
PRESS RELEASE
Dr. Reddy’s launches Toripalimab under brand name Zytorvi in India
28 Nov 2024 //
PRESS RELEASE
Aurigene reports Positive Ph 1 trial for CAR-T cell therapy in India
09 Oct 2024 //
PRESS RELEASE
Dr. Reddy’s receives positive opinion from EMA for Rituximab biosimilar
29 Jul 2024 //
PRESS RELEASE
Aurigene & Edity Enter Strategic Collaboration in Cell Therapy
03 Jul 2024 //
PRESS RELEASE
Zydus and Dr. Reddy`s announce agreement for marketing of Pertuzumab biosimilar
29 Jun 2024 //
PRESS RELEASE
Haleon sells nicotine replacement unit to Dr. Reddy`s for $633M
27 Jun 2024 //
PRESS RELEASE
Aurigene Opens Biologics Facility For Process, Clinical Manufacturing
03 Jun 2024 //
PRESS RELEASE
Alvotech, Dr. Reddy`s ink pact for commercialisation of denosumab
21 May 2024 //
PRESS RELEASE
Dr Reddy`s healthy Q4 results fail to impress brokerages
08 May 2024 //
MONEYCONTROL
Dr. Reddy`s Laboratories launches Versavo® (bevacizumab) in the UK
19 Mar 2024 //
PRESS RELEASE
Dr Reddy`s Laboratories jumps into the fray for Biogen`s biosimilars
16 Sep 2023 //
ECONOMIC TIMES
Dr Reddy`s application for biosimilar candidate accepted for review by USFDA
13 Jul 2023 //
ECONOMIC TIMES
Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC
05 Jun 2023 //
BUSINESSWIRE
Dr. Reddy`s subsidiary Aurigene plans $40M expansion in India
22 May 2023 //
PRESS RELEASE
Junshi Biosciences Announces Collaboration with Dr. Reddy™Toripalimab
07 May 2023 //
GLOBENEWSWIRE
Coya announces an Agreement with Dr. Reddy’s to License biosimilar Abatacept
21 Mar 2023 //
BUSINESSWIRE
Dr. Reddy`s announces the launch of Difluprednate Ophthalmic Emulsion 0.05%
28 Jan 2023 //
BUSINESSWIRE
Dr Reddy`s completes clinical studies of proposed rituximab biosimilar candidate
20 Jan 2023 //
ECONOMIC TIMES
